In conclusion and examining vitamin K-dependent proteins and vitamin K metabolites, this pilot study indicates that PXE patients demonstrate altered vitamin K metabolism compared to heterozygotes and non-carriers. The gene discussed is PROS1; the disease is Pseudoxanthoma elasticum.